KROS
Keros Therapeutics, Inc.
+0.27 (+2.51%)11.01USD93.5K成交股數218M市值–本益比(近四季)14.5股價營收比-100.0%營收年增(近四季)2026-11-04下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 2 · 21K · 1 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 4 · 101K · 4 |
| 其中 10b5-1 計畫賣出 | 1 筆 |
| 近 180 天 買進 · 賣出金額 | 53K · 191K |
| 近 180 天 淨額 | −138K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 | 08-20 | Newton Charles W. | Director | S 公開市場賣出(10b5-1) | 551 | 10.30 | 6K | 12.1K | SEC |
| 2026-08-18 | 08-20 | Tanini Annita | Corp. Controller & VP, Finance | S 公開市場賣出 | 1.2K | 10.29 | 13K | 45.1K | SEC |
| 2026-08-18 | 08-20 | Cho Esther | Chief Legal Officer | S 公開市場賣出 | 4.5K | 10.29 | 46K | 35.8K | SEC |
| 2026-08-18 | 08-20 | Lerner Lorena Raquel | Chief Scientific Officer | S 公開市場賣出 | 3.6K | 10.29 | 37K | 27.6K | SEC |
| 2026-08-17 | 08-19 | BIENAIME JEAN JACQUES | Director | P 公開市場買進 | 1.0K | 10.27 | 10K | 19.6K | SEC |
| 2026-07-15 | 07-17 | BIENAIME JEAN JACQUES | Director | P 公開市場買進 | 1.0K | 10.61 | 11K | 18.6K | SEC |
| 2026-07-01 | 07-06 | Prener Anne | Director | A 獲配股票 | 13.8K | – | – | 13.8K | SEC |
| 2026-06-15 | 06-17 | BIENAIME JEAN JACQUES | Director | P 公開市場買進 | 1.0K | 10.19 | 10K | 17.6K | SEC |
| 2026-06-11 | 06-15 | Newton Charles W. | Director | S 公開市場賣出(10b5-1) | 550 | 10.04 | 6K | 12.7K | SEC |
| 2026-06-04 | 06-08 | Farzan Nima | Director | S 公開市場賣出(10b5-1) | 2.6K | 10.73 | 28K | 9.8K | SEC |
| 2026-06-04 | 06-08 | Knowles Julius | Director | S 公開市場賣出(10b5-1) | 2.6K | 10.73 | 28K | 11.0K | SEC |
| 2026-06-04 | 06-05 | Seth Alpna | Director | S 公開市場賣出(10b5-1) | 2.6K | 10.72 | 28K | 9.8K | SEC |
| 2026-06-03 | 06-05 | Knowles Julius | Director | A 獲配股票 | 7.1K | – | – | 13.6K | SEC |
| 2026-06-03 | 06-05 | GRAY MARY ANN | Director | A 獲配股票 | 7.1K | – | – | 12.4K | SEC |
| 2026-06-03 | 06-05 | Seth Alpna | Director | A 獲配股票 | 7.1K | – | – | 12.4K | SEC |
| 2026-06-03 | 06-05 | Farzan Nima | Director | A 獲配股票 | 7.1K | – | – | 12.4K | SEC |
| 2026-06-03 | 06-05 | BIENAIME JEAN JACQUES | Director | A 獲配股票 | 7.1K | – | – | 16.6K | SEC |
| 2026-05-15 | 05-19 | BIENAIME JEAN JACQUES | Director | P 公開市場買進 | 1.0K | 10.58 | 11K | 9.4K | SEC |
| 2026-04-15 | 04-17 | BIENAIME JEAN JACQUES | Director | P 公開市場買進 | 1.0K | 11.70 | 12K | 8.4K | SEC |
| 2026-04-02 | 04-06 | Seehra Jasbir | CHIEF EXECUTIVE OFFICER | M 選擇權執行 | 55.0K | 0.30 | 17K | 441K | SEC |
| 2026-03-09 | 03-11 | Newton Charles W. | Director | A 獲配股票 | 13.2K | – | – | 13.2K | SEC |
| 2026-03-09 | 03-11 | BIENAIME JEAN JACQUES | Director | P 公開市場買進 | 2.0K | 11.21 | 22K | 7.5K | SEC |
| 2026-02-19 | 02-20 | Seehra Jasbir | CHIEF EXECUTIVE OFFICER | S 公開市場賣出 | 7.0K | 16.17 | 113K | 386K | SEC |
| 2026-02-18 | 02-20 | Lerner Lorena Raquel | Chief Science Officer | S 公開市場賣出 | 3.9K | 16.35 | 63K | 31.1K | SEC |
| 2026-02-18 | 02-20 | Regnante Keith | CHIEF FINANCIAL OFFICER | S 公開市場賣出 | 4.7K | 16.35 | 77K | 39.3K | SEC |
| 2026-02-18 | 02-20 | Cho Esther | SVP, General Counsel | S 公開市場賣出 | 4.7K | 16.35 | 78K | 39.8K | SEC |
| 2025-11-21 | 12-18 | ORBIMED ADVISORS LLC | Director | D 處分 | 140K | 17.75 | 2.5M | 759K | SEC |
| 2025-11-21 | 12-18 | ORBIMED ADVISORS LLC | Director | D 處分 | 74.5K | 17.75 | 1.3M | 45.1K | SEC |
| 2025-11-21 | 12-18 | OrbiMed Capital GP VII LLC | Director | D 處分 | 140K | 17.75 | 2.5M | 759K | SEC |
| 2025-11-21 | 12-18 | OrbiMed Capital GP VII LLC | Director | D 處分 | 74.5K | 17.75 | 1.3M | 45.1K | SEC |
| 2025-11-21 | 12-18 | Knowles Julius | Director | D 處分 | 130K | 17.75 | 2.3M | 102K | SEC |
| 2025-11-21 | 12-18 | OrbiMed Genesis GP LLC | Director | D 處分 | 74.5K | 17.75 | 1.3M | 45.1K | SEC |
| 2025-11-21 | 12-18 | Knowles Julius | Director | D 處分 | 192K | 17.75 | 3.4M | 150K | SEC |
| 2025-11-21 | 12-18 | GORDON CARL L | Director | D 處分 | 74.5K | 17.75 | 1.3M | 45.1K | SEC |
| 2025-11-21 | 12-18 | GORDON CARL L | Director | D 處分 | 140K | 17.75 | 2.5M | 759K | SEC |
| 2025-11-21 | 12-18 | OrbiMed Genesis GP LLC | Director | D 處分 | 140K | 17.75 | 2.5M | 759K | SEC |
| 2025-10-15 | 10-17 | Pontifax Late Stage Fund L.P. | TenPercentOwner | S 公開市場賣出 | 1.1M | 17.75 | 19.9M | 0 | SEC |
| 2025-10-15 | 10-17 | Pontifax Late Stage Fund L.P. | TenPercentOwner | S 公開市場賣出 | 2.3M | 17.75 | 40.6M | 0 | SEC |
| 2025-10-15 | 10-17 | Pontifax Management 4 G.P. (2015) Ltd. | TenPercentOwner | S 公開市場賣出 | 155K | 17.75 | 2.8M | 0 | SEC |
| 2025-10-15 | 10-17 | Pontifax Management 4 G.P. (2015) Ltd. | TenPercentOwner | S 公開市場賣出 | 1.1M | 17.75 | 19.9M | 0 | SEC |
| 2025-10-15 | 10-17 | Pontifax Management 4 G.P. (2015) Ltd. | TenPercentOwner | S 公開市場賣出 | 2.3M | 17.75 | 40.6M | 0 | SEC |
| 2025-10-15 | 10-17 | Pontifax (Israel) IV, L.P. | TenPercentOwner | S 公開市場賣出 | 155K | 17.75 | 2.8M | 0 | SEC |
| 2025-10-15 | 10-17 | Pontifax (Israel) IV, L.P. | TenPercentOwner | S 公開市場賣出 | 1.1M | 17.75 | 19.9M | 0 | SEC |
| 2025-10-15 | 10-17 | Pontifax (Israel) IV, L.P. | TenPercentOwner | S 公開市場賣出 | 2.3M | 17.75 | 40.6M | 0 | SEC |
| 2025-10-15 | 10-17 | Pontifax (China) IV L.P. | TenPercentOwner | S 公開市場賣出 | 155K | 17.75 | 2.8M | 0 | SEC |
| 2025-10-15 | 10-17 | Pontifax (China) IV L.P. | TenPercentOwner | S 公開市場賣出 | 1.2M | 17.75 | 21.8M | 0 | SEC |
| 2025-10-15 | 10-17 | Pontifax (China) IV L.P. | TenPercentOwner | S 公開市場賣出 | 1.1M | 17.75 | 19.9M | 0 | SEC |
| 2025-10-15 | 10-17 | Pontifax (China) IV L.P. | TenPercentOwner | S 公開市場賣出 | 2.3M | 17.75 | 40.6M | 0 | SEC |
| 2025-10-15 | 10-17 | Pontifax (Cayman) IV L.P. | TenPercentOwner | S 公開市場賣出 | 155K | 17.75 | 2.8M | 0 | SEC |
| 2025-10-15 | 10-17 | Pontifax (Cayman) IV L.P. | TenPercentOwner | S 公開市場賣出 | 1.2M | 17.75 | 21.8M | 0 | SEC |
| 2025-10-15 | 10-17 | Pontifax (Cayman) IV L.P. | TenPercentOwner | S 公開市場賣出 | 1.1M | 17.75 | 19.9M | 0 | SEC |
| 2025-10-15 | 10-17 | Pontifax (Cayman) IV L.P. | TenPercentOwner | S 公開市場賣出 | 2.3M | 17.75 | 40.6M | 0 | SEC |
| 2025-10-15 | 10-17 | Nussbaum Ran | Director,TenPercentOwner | S 公開市場賣出 | 155K | 17.75 | 2.8M | 0 | SEC |
| 2025-10-15 | 10-17 | Pontifax (Israel) IV, L.P. | TenPercentOwner | S 公開市場賣出 | 1.2M | 17.75 | 21.8M | 0 | SEC |
| 2025-10-15 | 10-17 | Nussbaum Ran | Director,TenPercentOwner | S 公開市場賣出 | 1.2M | 17.75 | 21.8M | 0 | SEC |
| 2025-10-15 | 10-17 | Nussbaum Ran | Director,TenPercentOwner | S 公開市場賣出 | 1.1M | 17.75 | 19.9M | 0 | SEC |
| 2025-10-15 | 10-17 | Nussbaum Ran | Director,TenPercentOwner | S 公開市場賣出 | 2.3M | 17.75 | 40.6M | 0 | SEC |
| 2025-10-15 | 10-17 | Pontifax Management 4 G.P. (2015) Ltd. | TenPercentOwner | S 公開市場賣出 | 1.2M | 17.75 | 21.8M | 0 | SEC |
| 2025-10-15 | 10-17 | Kariv Tomer | Director,TenPercentOwner | S 公開市場賣出 | 155K | 17.75 | 2.8M | 0 | SEC |
| 2025-10-15 | 10-17 | Pontifax Late Stage Fund L.P. | TenPercentOwner | S 公開市場賣出 | 155K | 17.75 | 2.8M | 0 | SEC |
| 2025-10-15 | 10-17 | Kariv Tomer | Director,TenPercentOwner | S 公開市場賣出 | 1.2M | 17.75 | 21.8M | 0 | SEC |
| 2025-10-15 | 10-17 | Pontifax Late Stage Fund L.P. | TenPercentOwner | S 公開市場賣出 | 1.2M | 17.75 | 21.8M | 0 | SEC |
| 2025-10-15 | 10-17 | Pontifax Late Stage GP Ltd. | TenPercentOwner | S 公開市場賣出 | 155K | 17.75 | 2.8M | 0 | SEC |
| 2025-10-15 | 10-17 | Kariv Tomer | Director,TenPercentOwner | S 公開市場賣出 | 1.1M | 17.75 | 19.9M | 0 | SEC |
| 2025-10-15 | 10-17 | Pontifax Late Stage GP Ltd. | TenPercentOwner | S 公開市場賣出 | 1.2M | 17.75 | 21.8M | 0 | SEC |
| 2025-10-15 | 10-17 | Pontifax Late Stage GP Ltd. | TenPercentOwner | S 公開市場賣出 | 1.1M | 17.75 | 19.9M | 0 | SEC |
| 2025-10-15 | 10-17 | Pontifax Late Stage GP Ltd. | TenPercentOwner | S 公開市場賣出 | 2.3M | 17.75 | 40.6M | 0 | SEC |
| 2025-10-15 | 10-17 | Kariv Tomer | Director,TenPercentOwner | S 公開市場賣出 | 2.3M | 17.75 | 40.6M | 0 | SEC |
| 2025-10-15 | 10-15 | ADAR1 Capital Management, LLC | TenPercentOwner | S 公開市場賣出 | 743K | 17.75 | 13.2M | 0 | SEC |
| 2025-10-15 | 10-15 | ADAR1 Capital Management, LLC | TenPercentOwner | S 公開市場賣出 | 4.4M | 17.75 | 77.9M | 0 | SEC |
| 2025-10-15 | 10-15 | ADAR1 Capital Management GP, LLC | TenPercentOwner | S 公開市場賣出 | 743K | 17.75 | 13.2M | 0 | SEC |
| 2025-10-15 | 10-15 | ADAR1 Capital Management GP, LLC | TenPercentOwner | S 公開市場賣出 | 255K | 17.75 | 4.5M | 0 | SEC |
| 2025-10-15 | 10-15 | ADAR1 Capital Management GP, LLC | TenPercentOwner | S 公開市場賣出 | 4.4M | 17.75 | 77.9M | 0 | SEC |
| 2025-10-15 | 10-15 | Schneeberger Daniel | TenPercentOwner | S 公開市場賣出 | 743K | 17.75 | 13.2M | 0 | SEC |
| 2025-10-15 | 10-15 | Schneeberger Daniel | TenPercentOwner | S 公開市場賣出 | 255K | 17.75 | 4.5M | 0 | SEC |
| 2025-10-15 | 10-15 | Schneeberger Daniel | TenPercentOwner | S 公開市場賣出 | 4.4M | 17.75 | 77.9M | 0 | SEC |
| 2025-10-15 | 10-15 | ADAR1 Partners, LP | TenPercentOwner | S 公開市場賣出 | 743K | 17.75 | 13.2M | 0 | SEC |
| 2025-10-15 | 10-15 | ADAR1 Capital Management, LLC | TenPercentOwner | S 公開市場賣出 | 255K | 17.75 | 4.5M | 0 | SEC |
| 2025-10-15 | 10-15 | ADAR1 Partners, LP | TenPercentOwner | S 公開市場賣出 | 255K | 17.75 | 4.5M | 0 | SEC |
| 2025-10-15 | 10-15 | ADAR1 Partners, LP | TenPercentOwner | S 公開市場賣出 | 4.4M | 17.75 | 77.9M | 0 | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | 2.8M | 30.2M | 新進 | 新進 |
| BlackRock, Inc. | 2.8M | 29.9M | 新進 | 新進 |
| AQR CAPITAL MANAGEMENT LLC | 968K | 10.4M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 834K | 8.9M | 新進 | 新進 |
| ORBIMED ADVISORS LLC | 759K | 8.1M | 新進 | 新進 |
| FEDERATED HERMES, INC. | 700K | 7.5M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 653K | 7.0M | 新進 | 新進 |
| MACKENZIE FINANCIAL CORP | 628K | 6.7M | 新進 | 新進 |
| Madison Avenue Partners, LP | 627K | 6.7M | 新進 | 新進 |
| Qube Research & Technologies Ltd | 609K | 6.5M | 新進 | 新進 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 605K | 6.5M | 新進 | 新進 |
| STATE STREET CORP | 541K | 5.8M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 511K | 5.5M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 461K | 4.9M | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 396K | 4.2M | 新進 | 新進 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 359K | 3.8M | 新進 | 新進 |
| 德劭 D. E. Shaw & Co., Inc. | 267K | 2.9M | 新進 | 新進 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 265K | 2.8M | 新進 | 新進 |
| Nuveen, LLC | 248K | 2.7M | 新進 | 新進 |
| ADAR1 Capital Management, LLC | 247K | 2.6M | 新進 | 新進 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 247K | 2.6M | 新進 | 新進 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 233K | 2.5M | 新進 | 新進 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 185K | 2.0M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 178K | 1.9M | 新進 | 新進 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 159K | 1.7M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 132 -19 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 132 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 20.0M · 100.0% |
| 合計季末市值 | 210M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 1.2M |
|---|---|
| 與上期比 | +1.4% |
| 佔流通股數 | 5.88% |
| 日均成交量 | 191K |
| 回補天數 | 6.1 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 1.2M | +1.4% | 5.88% | 191K | 6.1 |
| 2026-08-14 | 1.1M | +16.6% | 5.79% | 243K | 4.7 |
| 2026-07-31 | 986K | -6.9% | 4.97% | 166K | 5.9 |
| 2026-07-15 | 1.1M | +3.2% | 5.34% | 259K | 4.1 |
| 2026-06-30 | 1.0M | -27.1% | 5.18% | 404K | 2.5 |
| 2026-06-15 | 1.4M | -6.7% | 7.10% | 213K | 6.6 |
| 2026-05-29 | 1.5M | -11.5% | 7.61% | 332K | 4.5 |
| 2026-05-15 | 1.7M | +20.4% | 8.60% | 366K | 4.7 |
| 2026-04-30 | 1.4M | +1.2% | 7.14% | 264K | 5.4 |
| 2026-04-15 | 1.4M | -6.4% | 7.06% | 404K | 3.5 |
| 2026-03-31 | 1.5M | -24.9% | 7.54% | 569K | 2.6 |
| 2026-03-13 | 2.0M | -2.1% | 10.03% | 565K | 3.5 |
| 2026-02-27 | 2.0M | -14.8% | 10.24% | 308K | 6.6 |
| 2026-02-13 | 2.4M | +4.7% | 12.02% | 270K | 8.8 |
| 2026-01-30 | 2.3M | -2.9% | 11.48% | 258K | 8.8 |
| 2026-01-15 | 2.3M | -5.6% | 11.83% | 446K | 5.3 |
| 2025-12-31 | 2.5M | -7.7% | 12.53% | 542K | 4.6 |
| 2025-12-15 | 2.7M | -16.6% | 13.58% | 886K | 3.0 |
| 2025-11-28 | 3.2M | -52.4% | 16.29% | 1.3M | 2.4 |
| 2025-11-14 | 6.8M | +15.7% | 34.20% | 1.3M | 5.4 |
| 2025-10-31 | 5.9M | +53.5% | 29.57% | 1.1M | 5.4 |
| 2025-10-15 | 3.8M | -1.3% | 19.26% | 1.0M | 3.8 |
| 2025-09-30 | 3.9M | -16.2% | 19.51% | 323K | 12.0 |
| 2025-09-15 | 4.6M | +2.6% | 23.29% | 322K | 14.4 |
| 2025-08-29 | 4.5M | -6.9% | 22.70% | 544K | 8.3 |
| 2025-08-15 | 4.8M | -0.1% | 24.38% | 433K | 11.2 |